Commit To Purchase Deciphera Pharmaceuticals At $7.50, Earn 15.7% Annualized Using Options
April 16, 2024 at 12:47 PM EDT
Investors eyeing a purchase of Deciphera Pharmaceuticals Inc (DCPH) shares, but cautious about paying the going market price of $14.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May put at the $7.50 strike, which has a bid at the time of this writing of 10 cents..